Standardizing the Clinical Approach to Cancer Therapy‐Related Cardiac Dysfunction: Applying Cardio‐Oncology Guidelines as a Practical Tool for Hematology and Oncology Providers

By offering a structured, user-friendly framework, this document seeks to bridge the implementation gap between oncology and cardiology disciplines. Our goal is to equip oncology providers with accessible tools that facilitate early recognition, consistent surveillance, and timely referral, thereby preserving cancer treatment intensity while minimizing cardiovascular morbidity.

Authors

Institutions

Publication Details

Journal
Cancer Medicine
Published
2026-03-27
DOI
https://doi.org/10.1002/cam4.71682
Primary Topic
Chemotherapy-induced cardiotoxicity and mitigation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Standardizing the Clinical Approach to Cancer Therapy‐Related Cardiac Dysfunction: Applying Cardio‐Oncology Guidelines as a Practical Tool for Hematology and Oncology Providers

Teresa López‐Fernández, Suparna C. Clasen, Borja Ibáñez, Alessandra Ferrajoli et al.
Cancer Medicine
Chemotherapy-induced cardiotoxicity and mitigation
article

Standardizing the Clinical Approach to Cancer Therapy‐Related Cardiac Dysfunction: Applying Cardio‐Oncology Guidelines as a Practical Tool for Hematology and Oncology Providers

Teresa López‐Fernández, Suparna C. Clasen, Borja Ibáñez, Alessandra Ferrajoli, Johannes M. Herrmann, Anecita Fadol, Anne Hudson Blaes, Sue Koob, Michael G. Fradley, Eric H. Yang, Stephen Casselli, Kasey J. Leger, Gregory A. Durm, S. F. Dent, Anita Deswal, Alexander R. Lyon, Bogda Koczwara, N. G. Choon Ta, Daniel Lenihan, Jennifer E. Liu, Abdelrahman Ali, John Teerlink, Susan Halli Demeter
article en

Abstract

By offering a structured, user-friendly framework, this document seeks to bridge the implementation gap between oncology and cardiology disciplines. Our goal is to equip oncology providers with accessible tools that facilitate early recognition, consistent surveillance, and timely referral, thereby preserving cancer treatment intensity while minimizing cardiovascular morbidity.

Cancer MedicineVol. 15(4)
Indiana University Health (US), University of Minnesota (US), San Francisco VA Medical Center (US), Mayo Clinic (US), Memorial Sloan Kettering Cancer Center (US), The University of Texas MD Anderson Cancer Center (US), University of California, Los Angeles (US), Flinders University (AU), Hospital of the University of Pennsylvania (US), Flinders Medical Centre (AU), Chinese Preventive Medicine Association (CN), Royal Brompton Hospital (GB), Hospital La Paz Institute for Health Research (ES), Saint Francis Medical Center (US), Seattle Children's Hospital (US), Mayo Clinic in Arizona (US), Hospital Universitario Fundación Jiménez Díaz (ES), National Heart Centre Singapore (SG), Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, University of Rochester (US), The University of Texas Medical Branch at Galveston (US), Indiana University – Purdue University Indianapolis (US), Universidad Autónoma de Madrid (ES), International Society of Nephrology (BE)
Peace, Justice and strong institutions
Openalex Percentile: Top 14%
Chemotherapy-induced cardiotoxicity and mitigation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.